Payer Strategy for Healthtech Founders

Follow the benefit to the contracting entity.

I would start a payer strategy with the contract’s economic beneficiary. The organization approving a service may not retain its benefit for long enough to recover the investment. A proposal must therefore specify the population, attribution period, financing responsibility and route through which value reaches the buyer. An employer, a health plan, an administrator and a risk-bearing provider can support the same clinical objective while facing different cash flows and obligations.

The value proposition should identify a controllable mechanism. Reducing avoidable administrative work can support a different purchase decision from improving quality or reducing future medical expenditure. Combining those claims into one savings figure obscures the evidence and timing required for each. I would price the service using the buyer’s actual scope of responsibility, keep transfers between organizations separate from new value, and model the effect of enrollment changes and incomplete participation.

The contract should then align payment with what the supplier can deliver and the buyer can verify. A service fee can finance necessary capacity; a performance component can reward an agreed result when attribution and measurement are credible. Putting all compensation at risk does not create causal evidence and may encourage selection of easier members. Before expansion, I would require a defensible comparison, subgroup and missing-data reporting, a full cost-to-serve account, and a clear answer to who funds the service if outcomes improve without near-term medical savings.